Effect of Chunghyuldan in chronic oxazolone-induced mouse dermatitis

Biological and Pharmaceutical Bulletin

Volumn 28, Issue 6, 2005, Pages 1079-1082

  Wee, Sung Sook ^a   Shin, Yong Wook ^a   Bae, Eun Ah ^a   Kim, Dong Hyun ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Chunghyuldan; Contact dermatitis; COX 2; Daio Orengedokuto; IFN ; Psoriasis

Indexed keywords

CHUNGHYULDAN; CYCLOOXYGENASE 2; GAMMA INTERFERON; HERBACEOUS AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 4; MESSENGER RNA; OXAZOLONE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIISCHEMIC ACTIVITY; ANTIPSORIASIS EFFECT; ARTICLE; CONTACT DERMATITIS; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; EDEMA; FEMALE; HELPER CELL; INTESTINE FLORA; MACROPHAGE; MICROBIAL METABOLISM; MOUSE; NONHUMAN; PSORIASIS;

ANIMALS; CHRONIC DISEASE; DERMATITIS; DRUG ERUPTIONS; DRUGS, CHINESE HERBAL; FEMALE; MICE; MICE, INBRED BALB C; OXAZOLONE;

EID: 21144432105     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.28.1079     Document Type: Article

References (16)

1. Austin L. M., Ozawa M., Kikuchi T., Walters I. B., Krueger J. G., J. Invest. Dermatol., 113, 752-759 (1999).
2. Nicoloff B. J., Arch. Dermatol., 127, 871-884 (1991).
3. Ovigne J.-M., Baker B. S., Brown D. W., Powles A. V., Fry L., Exp. Dermatol., 10, 168-174 (2001).
4. Hernandez G. L., Volpert O. V., Iniguez M. A., Lorenzo E., Martinez-Martinez S., Grau R., Fresno M., Redondo J. M., J. Exp. Med., 193, 607-620 (2001).
5. Schafer-Korting M., Schmid M. H., Korting H. C., Drug Safety, 14, 375-385 (1996).
6. Sakuma S., Higashi Y., Sato N., Sasakawa T., Sengoku T., Ohkubo Y., Amaya T., Goto T., Int. Immunopharmacol., 1, 1219-1226 (2001).
7. Friedman E. S., LaNatra N., Stiller M. J., J. Cutan. Med. Surg., 6, 449-459 (2002).
8. Reynolds N. J., Voorhees J. J., Fisher G. H., Br. J. Dermatol., 139, 16-22 (1998).
9. Fujii Y., Takeuchi H., Tanaka K., Sakuma S., Ohkubo Y., Mutoh S., Eur. J. Pharmacol., 456, 115-121 (2002).
10. Sampson J. H., Raman A., Karlsen G., Navsaria H., Leigh I. M., Phytomedicine, 8, 230-235 (2001).
11. Kobayashi H., Takahashi K., Mizuno N., Kutsuna H., Ishii M., eCAM, 1, 49-62 (2004).
12. Cho K.-H., Kim Y.-S., Bae H.-S., Moon S.-K., Jung W. S., Park E. K., Kim D.-H., Biol. Pahrm. Bull., 27, 1810-1813 (2004).
13. Chi Y. S., Lim H., Park H., Kim H. P., Biochem. Pharmacol., 66, 1271-1278 (2003).
14. Abd-El-Aleem S. A., Feguson M. W., Appleton I., Bhowmick A., McCollum C. N., Ireland G. W., J. Pathol., 195, 616-623 (2001).
15. Bruch-Gerharz D., Fehsel K., Suschek C., Michel G., Ruzicka T., Kolba-Bachofen V., J. Exp. Med., 184, 2007-2012 (1996).
16. Bruch-Gerharz D., Ruzicka T., Kolb-Bachofen V., J. Invest. Dermatol., 110, 1-7 (1998).